Xeris Biopharma Holdings, Inc. Share Price
NASDAQ: XERS | Small CapXeris Biopharma Holdings, Inc. Stock Performance
Open $7.24 | Prev. Close $8.11 | Circuit Range N/A |
Day Range $7.06 - $7.42 | Year Range $5.25 - $10.07 | Volume 2,04,300 |
Average Traded $7.22 |
Xeris Biopharma Holdings, Inc. Share Price Today
As of 9 August 2026, Xeris Biopharma Holdings, Inc.'s share price is $7.36. The stock opened at $7.24, compared to its previous close of $8.11. During today's trading session, Xeris Biopharma Holdings, Inc.'s share price traded between $7.06 and $7.42, with an average price of $7.24. Over the past 52 weeks, the stock has recorded a high of $10.07 and a low of $5.25. In terms of performance, Xeris Biopharma Holdings, Inc.'s share price has risen by 20.46% over the last six months and is down 5.88% on a year-on-year basis.
Xeris Biopharma Holdings, Inc. Share Price Chart
Xeris Biopharma Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.18B | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $0.00 | Revenue (TTM) $291.85M | Return On Equity (TTM) 4.05% |
Profit Margin 0.19% | Debt to Equity 8.00 | Quarterly Earnings Growth YoY 103.95% |
Xeris Biopharma Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Xeris Biopharma Holdings, Inc. Annual Profit & Loss
All figures in USD
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Xeris Biopharma Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.13 | $7.36 | -8.91% |
Jul 2026 | $7.95 | $8.08 | +2.02% |
Jun 2026 | $6.13 | $7.92 | +28.68% |
May 2026 | $6.17 | $6.16 | +0.57% |
Apr 2026 | $5.88 | $6.12 | +5.61% |
Mar 2026 | $6.98 | $5.79 | -5.16% |
Feb 2026 | $7.33 | $6.11 | -16.98% |
Jan 2026 | $7.85 | $7.36 | -6.12% |
Dec 2025 | $7.09 | $7.84 | +9.04% |
Nov 2025 | $9.59 | $7.19 | -25.80% |
Oct 2025 | $8.07 | $9.69 | +18.90% |
Sep 2025 | $7.77 | $8.15 | +4.22% |
XERS Share Price FAQs
What is Xeris Biopharma Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Xeris Biopharma Holdings, Inc. stock?
What is XERS's market capitalisation today?
What is XERS's net income for the last quarter?
What is the 5 year returns of XERS?
What is the high & low stock price of XERS today?
Can I buy XERS shares in India?